Defiance Nasdaq Junior Biotechnology (IBBJ) ETF Holdings & Analysis

What IBBJ does

This investment vehicle's primary objective is to track the overall performance, measured by total return, of the NASDAQ Junior Biotechnology Index, before accounting for any associated fees or expenses. The index itself is a rule-based compilation of U.S.-listed small-capitalization ("junior") biotechnology companies, carefully selected from the broader spectrum of businesses found within the NASDAQ Biotechnology Index. The fund typically implements a "replication" investment strategy, which means it generally acquires positions in all the component securities of its benchmark index, aiming to maintain their proportional weightings. This fund is designated as non-diversified.

Fund profile

Top holdings

Sector allocation

Geographic allocation

PortView Portfolio Insights

PortView analyzes how IBBJ fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Related securities

Related stocks

Frequently asked questions

What does IBBJ track?

IBBJ is the Defiance Nasdaq Junior Biotechnology ETF, a Other ETF.

What is the expense ratio of IBBJ?

Expense ratio data for IBBJ is shown on the page when available from our data provider.

What are the largest holdings in IBBJ?

Top holdings include Cash&Other, PDLI, 761CVR026.

How can PortView analyze IBBJ overlap with other ETFs?

PortView computes the holdings overlap between IBBJ and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.